AARTI DRUGS LTD. - stock earnings
AARTIDRUGS.BO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 366.7 million INR | 6.1 billion INR |
| 2023Q3 | 395.9 million INR | 6.4 billion INR |
| 2023Q2 | 478.5 million INR | 6.6 billion INR |
| 2023Q1 | 560.9 million INR | 7.4 billion INR |
| 2022Q4 | 366.8 million INR | 6.6 billion INR |
| 2022Q3 | 387.5 million INR | 6.9 billion INR |
| 2022Q2 | 347.9 million INR | 6.2 billion INR |
| 2022Q1 | 347.9 million INR | 6.2 billion INR |
| 2021Q4 | 582.9 million INR | 6.3 billion INR |
| 2021Q3 | 425.9 million INR | 5.8 billion INR |
| 2021Q2 | 488.1 million INR | 5.8 billion INR |
| 2021Q1 | 516.5 million INR | 5.0 billion INR |
| 2020Q4 | 680.4 million INR | 5.3 billion INR |
| 2020Q3 | 752.7 million INR | 5.8 billion INR |
| 2020Q2 | 854.5 million INR | 5.4 billion INR |
| 2020Q1 | 588.6 million INR | 4.5 billion INR |
| 2019Q4 | 277.8 million INR | 4.7 billion INR |
| 2019Q3 | 323.1 million INR | 4.8 billion INR |
| 2019Q2 | 224.5 million INR | 4.1 billion INR |
| 2019Q1 | 274.4 million INR | 4.6 billion INR |
| 2018Q4 | 208.9 million INR | 3.8 billion INR |
| 2018Q3 | 180.5 million INR | 3.5 billion INR |
| 2018Q2 | 233.7 million INR | 3.7 billion INR |
| 2018Q1 | 239.9 million INR | 3.3 billion INR |
| 2017Q4 | 233.3 million INR | 3.4 billion INR |
| 2017Q3 | 236.0 million INR | 3.2 billion INR |
| 2017Q2 | 113.8 million INR | 2.6 billion INR |
| 2017Q1 | 207.3 million INR | 3.0 billion INR |
| 2016Q4 | 178.5 million INR | 2.9 billion INR |
| 2016Q3 | 220.7 million INR | 3.2 billion INR |
| 2016Q2 | 199.4 million INR | 2.9 billion INR |
| 2016Q1 | 185.9 million INR | 3.1 billion INR |
| 2015Q4 | 170.3 million INR | 2.7 billion INR |
| 2015Q3 | 157.1 million INR | 2.7 billion INR |
| 2015Q2 | 170.5 million INR | 2.6 billion INR |
| 2015Q1 | 185.1 million INR | 2.9 billion INR |
| 2014Q4 | 227.5 million INR | 2.6 billion INR |
| 2014Q3 | 187.5 million INR | 2.9 billion INR |
| 2014Q2 | 172.4 million INR | 2.6 billion INR |
| 2014Q1 | 219.5 million INR | 2.8 billion INR |
| 2013Q4 | 141.6 million INR | 2.2 billion INR |
| 2013Q3 | 137.6 million INR | 2.5 billion INR |
| 2013Q2 | 118.4 million INR | 2.2 billion INR |
| 2013Q1 | 138.1 million INR | 2.2 billion INR |
| 2012Q4 | 109.4 million INR | 2.0 billion INR |
| 2012Q3 | 116.2 million INR | 2.2 billion INR |
| 2012Q2 | 88.8 million INR | 1.9 billion INR |
AARTIDRUGS.BO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.7 billion INR | 27.2 billion INR |
| 2022 | 2.1 billion INR | 24.9 billion INR |
| 2021 | 2.8 billion INR | 21.5 billion INR |
| 2020 | 1.4 billion INR | 18.1 billion INR |
| 2019 | 897.5 million INR | 15.6 billion INR |
| 2018 | 823.1 million INR | 12.4 billion INR |
| 2017 | 805.6 million INR | 12.0 billion INR |
| 2016 | 687.2 million INR | 11.3 billion INR |
| 2015 | 772.5 million INR | 10.9 billion INR |
| 2014 | 617.1 million INR | 9.7 billion INR |
| 2013 | 452.4 million INR | 8.2 billion INR |
| 2012 | 224.6 million INR | 6.6 billion INR |
| 2011 | 237.1 million INR | 5.0 billion INR |
| 2010 | 282.3 million INR | 4.8 billion INR |
| 2009 | 159.7 million INR | 3.8 billion INR |
| 2008 | 137.4 million INR | 3.1 billion INR |
| 2007 | 137.7 million INR | 2.9 billion INR |
AARTIDRUGS.BO
Price: ₹488.45
Dividend Yield: 0.00%
Forward Dividend Yield: 0.20%
Payout Ratio: 5.12%
Dividend Per Share: 1.00 INR
Earnings Per Share: 18.58 INR
P/E Ratio: 26
Exchange: BSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 42.9 billion
Average Dividend Frequency: 2
Years Paying Dividends: 3